The Efficacy of Galantamine on the Attention and the Frontal Function of the Patients With Dementia of Alzheimer Type

NCT00216515 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

102

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer Disease

Interventions

DRUG: galantamine hydrobromide

Sponsor

Janssen Korea, Ltd., Korea